Literature DB >> 11819676

Expressions of chromogranin A and cathepsin D in human primary hepatocellular carcinoma.

Xiao-Feng Huang, Chun-Mei Wang, Xiao-Wen Dai, Zhen- Jiang Li, Bo-Rong Pan, Li-Bin Yu, Bin Qian, Li Fang.   

Abstract

AIM:To determine the expression and clinical significance of chromogranin A and cathepsin D in hepatocellular carcinoma (HCC).
METHODS: Double immunofluorescence stain-ing techniques combined with laser confocal scanning microscopy (LSCM) was used to investigate chromogranin A and cathepsin D expressions in 85 HCC patients.
RESULTS: Cathepsin D was expressed in 3 normal liver tissues, while in HCC the staining showed regional variation and the fraction of strongly stained cells increased as the tumors became less differentiated and usually clinically more malignant.Cells which showed strong positivity for cathepsin D were present in 71/85(83.5%) cases. Strong expression of cathepsin D in cancer cells was related to histopathological features. They were more common in grade 3-4 (26/28, 92.9%) and grade 2 (46/53, 86.8%) tumors than in grade 1 tumors (1/4, 25.0%)(P <0.01). No significant correlation was found between age and cathepsin D expression. In patients with positive cathepsin D reaction, the mean age was 52.1± 2.8 years (range 32-68 years) and in the group with negative reaction, the mean age was 51.3± 4.5 years (range 28-71 years). No obvious relationship was observed between CgA expression in cancer cells and the histopathological features. The CgA positive rate was 75.0% (3/4) in grade 1, 71.7% (38/53) in grade 2,and 71.4% (20/28) in grade 3-4(P >0.05) tumors. The coexpression of CgA and cathepsin D was found by double labeled immunofluorescence staining techniques. The processing of cathepsin D was disturbed in HCC cells and accumulated in the cells.Cathepsin D had proteolytic activity and autocrine mitogenic effect, suggesting their functions in invasion. These findings demonstrated that the expression of cathepsin D in HCC had prognostic value.
CONCLUSION: Chromogranin A and cathepsin D are expressed in a high proportion of HCC and the existence of cathepsin D in HCC might be related to processing of CgA. This is clearly a subject for further studies because of its potential clinical applications.

Entities:  

Year:  2000        PMID: 11819676      PMCID: PMC4688845          DOI: 10.3748/wjg.v6.i5.693

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

Review 2.  The role of cathepsin L in malignant transformation.

Authors:  S E Kane; M M Gottesman
Journal:  Semin Cancer Biol       Date:  1990-04       Impact factor: 15.707

3.  Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer.

Authors:  H Rochefort; V Cavailles; P Augereau; F Capony; T Maudelonde; I Touitou; M Garcia
Journal:  J Steroid Biochem       Date:  1989       Impact factor: 4.292

4.  The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease.

Authors:  M Morisset; F Capony; H Rochefort
Journal:  Biochem Biophys Res Commun       Date:  1986-07-16       Impact factor: 3.575

5.  Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa.

Authors:  M C Rio; J P Bellocq; J Y Daniel; C Tomasetto; R Lathe; M P Chenard; A Batzenschlager; P Chambon
Journal:  Science       Date:  1988-08-05       Impact factor: 47.728

Review 6.  Cathepsin D in the malignant progression of neoplastic diseases (review).

Authors:  G Leto; N Gebbia; L Rausa; F M Tumminello
Journal:  Anticancer Res       Date:  1992 Jan-Feb       Impact factor: 2.480

7.  Chromogranin A, chromogranin B and secretogranin II mRNAs in the pituitary and adrenal glands of various mammals. Regulation of chromogranin A, chromogranin B and secretogranin II mRNA levels by estrogen.

Authors:  R V Lloyd; K Hawkins; L Jin; E Kulig; K Fields
Journal:  Lab Invest       Date:  1992-09       Impact factor: 5.662

8.  Parathyroid hormone-related peptide expression in primary and metastatic liver tumours.

Authors:  T Roskams; M Willems; R V Campos; D J Drucker; S H Yap; V J Desmet
Journal:  Histopathology       Date:  1993-12       Impact factor: 5.087

9.  Human chromogranin A gene. Molecular cloning, structural analysis, and neuroendocrine cell-specific expression.

Authors:  A J Mouland; S Bevan; J H White; G N Hendy
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

10.  Purification and properties of cathepsin D from rat Yoshida ascites hepatoma AH-130.

Authors:  G Bonelli; J Kay; L Tessitore; R A Jupp; C Isidoro; C G Norey; R Autelli; A D Richards; F M Baccino
Journal:  Biol Chem Hoppe Seyler       Date:  1988-05
View more
  12 in total

1.  Molecular imaging of Cathepsin E-positive tumors in mice using a novel protease-activatable fluorescent probe.

Authors:  Wael R Abd-Elgaliel; Zobeida Cruz-Monserrate; Craig D Logsdon; Ching-Hsuan Tung
Journal:  Mol Biosyst       Date:  2011-09-20

2.  Localization of TRAIL/TRAILR in fetal pancreas.

Authors:  Li-Hua Chen; Xue-Song Liu; Wen-Yong Wang; Wei-Ning Han; Bo-Rong Pan; Bo-Quan Jin
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

3.  Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization.

Authors:  Lian-Jun Yang; Wen-Liang Wang
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

4.  P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection.

Authors:  Lun-Xiu Qin; Zhao-You Tang; Zeng-Chen Ma; Zhi-Quan Wu; Xin-Da Zhou; Qing-Hai Ye; Yuan Ji; Li-Wen Huang; Hu-Liang Jia; Hui-Chuan Sun; Lu Wang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

5.  Expression of liver cancer associated gene HCCA3.

Authors:  Z X Wang; G F Hu; H Y Wang; M C Wu
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

6.  Signal transduction of gap junctional genes, connexin32, connexin43 in human hepatocarcinogenesis.

Authors:  Xiang-Dong Ma; Xing Ma; Yan-Fang Sui; Weng-Liang Wang; Chun-Mei Wang
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

7.  Expression of gap junction genes connexin32 and connexin43 mRNAs and proteins, and their role in hepatocarcinogenesis.

Authors:  Xiang-Dong Ma; Xing Ma; Yan-Fang Sui; Wen-Liang Wang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

8.  Seek protein which can interact with hepatitis B virus X protein from human liver cDNA library by yeast two-hybrid system.

Authors:  Xiao-Zhong Wang; Xiang-Rong Jiang; Xiao-Chun Chen; Zhi-Xing Chen; Dan Li; Jian-Yin Lin; Qi-Min Tao
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

9.  The analysis of gamma-glutamyl transpeptidase gene in different type liver tissues.

Authors:  Guo-Qing Han; Cheng-Yong Qin; Rong-Hua Shu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

Review 10.  Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications.

Authors:  Gaetano Leto; Francesca M Tumminello; Marilena Crescimanno; Carla Flandina; Nicola Gebbia
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.